DISTINCT HEALTH Reports Fiscal Year Results with Adjusted Net Profit Soaring 139.7%

Stock News
03/25

DISTINCT HEALTH (02677) announced its annual results for the period ending December 31, 2025. The group achieved revenue of RMB 1.065 billion, representing an increase of 11.1% year-on-year. Net profit reached RMB 131 million, up 63.8% compared to the previous year. Adjusted net profit amounted to RMB 25.648 million, marking a significant rise of 139.7%. Basic earnings per share were RMB 9.68.

The year 2025 was one in which the company explored ways to stimulate growth momentum amid changes in the external macroeconomic environment. Guided by the strategic focus of "building an excellent reputation," the company strengthened its foundation in providing high-quality medical services and deepened its focus on the demand side. It advanced its strategy through initiatives such as upgrading service outlets, enhancing the user-centric mindset of medical teams, improving the competitiveness of core products, and developing artificial intelligence (AI) and digital capabilities, achieving steady organic growth. At the same time, the company continued to accumulate experience in mergers and acquisitions integration and honed team capabilities, laying a solid foundation for future development.

Throughout 2025, the company gained deep insights into and addressed core customer needs, establishing a robust customer relationship system. This strengthened customer trust and facilitated the conversion of users into loyal members, enabling long-term user retention. Both the number of member accounts and new members showed steady growth, while new customer conversion rates and member renewal rates remained at high levels, fully demonstrating the healthy development of the membership ecosystem and the notable effectiveness of the demand-side focus.

Word-of-mouth referrals have consistently been the company's primary method of customer acquisition. Its core reputation metric, the Net Promoter Score (NPS), improved from 86.2 to 87.3 year-on-year, maintaining an industry-leading position. The ratio of sales expenses to revenue stood at 1.5%, remaining low within the industry. These figures highlight the strong reputation of the company's brand and its advantage in scalable customer acquisition, providing solid support for high-quality user growth.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10